{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:02:28Z","timestamp":1789952548013,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272856"],"award-info":[{"award-number":["82272856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303742"],"award-info":[{"award-number":["82303742"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) is a common malignancy in men, and bone metastasis is a leading cause of mortality in advanced-stage PCa. This study aims to identify critical genes involved in PCa bone metastasis, exploring biomarkers for prognosis and precision treatment. Forkhead Box Q1 (FOXQ1) was identified as a potential key gene through screening of public databases, and was found to be markedly upregulated in bone metastatic PCa compared to primary PCa. FOXQ1 promotes PCa cell proliferation and metastasis while inhibiting apoptosis. Additionally, FOXQ1 recruits macrophages, promotes M2 polarization, and enhances osteoclast differentiation in the tumor microenvironment. Mechanistically, FOXQ1 activates the transcription of Glycosyltransferase 8 Domain Containing 2 (GLT8D2) by directly binding to its promoter, and GLT8D2 upregulates the expression of C-C Motif Chemokine Ligand 2 (CCL2) by enhancing its N-glycosylation, thereby promoting PCa bone metastasis. Collectively, these findings establish FOXQ1 as a key regulator of PCa bone metastasis through the GLT8D2\/CCL2 axis, and suggest that targeting this pathway may hold therapeutic promise for bone metastatic PCa.<\/jats:p>","DOI":"10.1038\/s41419-026-09046-9","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:57:25Z","timestamp":1782910645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FOXQ1 activates GLT8D2 to enhance CCL2 N-glycosylation and promote prostate cancer bone metastasis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7851-2759","authenticated-orcid":false,"given":"Zhiyue","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2284-2265","authenticated-orcid":false,"given":"Nan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7106-358X","authenticated-orcid":false,"given":"Linglan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqian","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Lu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-6102","authenticated-orcid":false,"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-302X","authenticated-orcid":false,"given":"Mingkun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-8077","authenticated-orcid":false,"given":"Shan-Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"9046_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"9046_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20240073","volume":"3","author":"G-Y Xie","year":"2025","unstructured":"Xie G-Y, Deng Y-H, Liu C-J, Guo A-Y, Lei Q. Comprehensive landscape of small non-coding RNAs in large and small extracellular vesicles from human serum and plasma. Interdiscip Med. 2025;3:e20240073.","journal-title":"Interdiscip Med"},{"key":"9046_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","volume":"6","author":"U Swami","year":"2020","unstructured":"Swami U, McFarland TR, Nussenzveig R, Agarwal N. Advanced prostate cancer: treatment advances and future directions. Trends Cancer. 2020;6:702\u201315.","journal-title":"Trends Cancer"},{"key":"9046_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","volume":"69","author":"DA Siegel","year":"2020","unstructured":"Siegel DA, O\u2019Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001\u20132017. Morb Mortal Wkly Rep. 2020;69:1473\u201380.","journal-title":"Morb Mortal Wkly Rep"},{"key":"9046_CR5","doi-asserted-by":"publisher","first-page":"999.","DOI":"10.3390\/ijms20040999","volume":"20","author":"L Xiang","year":"2019","unstructured":"Xiang L, Gilkes DM. The contribution of the immune system to bone metastasis pathogenesis. Int J Mol Sci. 2019;20:999.","journal-title":"Int J Mol Sci"},{"key":"9046_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.","journal-title":"J Hematol Oncol"},{"key":"9046_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.","journal-title":"Signal Transduct Target Ther"},{"key":"9046_CR8","doi-asserted-by":"publisher","first-page":"1099.","DOI":"10.3390\/life11101099","volume":"11","author":"Z Kaplan","year":"2021","unstructured":"Kaplan Z, Zielske SP, Ibrahim KG, Cackowski FC. Wnt and \u03b2-catenin signaling in the bone metastasis of prostate cancer. Life. 2021;11:1099.","journal-title":"Life"},{"key":"9046_CR9","doi-asserted-by":"publisher","first-page":"3934.","DOI":"10.3390\/cells11233934","volume":"11","author":"N Ben-Ghedalia-Peled","year":"2022","unstructured":"Ben-Ghedalia-Peled N, Vago R. Wnt signaling in the development of bone metastasis. Cells. 2022;11:3934.","journal-title":"Cells"},{"key":"9046_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","volume":"6","author":"RE Coleman","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Cl\u00e9zardin P, Chow E, Fallon M, et al. Bone metastases. Nat Rev Dis Primers. 2020;6:83.","journal-title":"Nat Rev Dis Primers"},{"key":"9046_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tig.2020.11.003","volume":"37","author":"L Herman","year":"2021","unstructured":"Herman L, Todeschini AL, Veitia RA. Forkhead transcription factors in health and disease. Trends Genet. 2021;37:460\u201375.","journal-title":"Trends Genet"},{"key":"9046_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00018-004-4365-8","volume":"62","author":"H Jonsson","year":"2005","unstructured":"Jonsson H, Peng SL. Forkhead transcription factors in immunology. Cell Mol Life Sci. 2005;62:397\u2013409.","journal-title":"Cell Mol Life Sci"},{"key":"9046_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34239-z","volume":"13","author":"AV Mitchell","year":"2022","unstructured":"Mitchell AV, Wu L, James Block C, Zhang M, Hackett J, Craig DB, et al. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Nat Commun. 2022;13:6548.","journal-title":"Nat Commun"},{"key":"9046_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molcel.2020.04.020","volume":"78","author":"A Erijman","year":"2020","unstructured":"Erijman A, Kozlowski L, Sohrabi-Jahromi S, Fishburn J, Warfield L, Schreiber J, et al. A high-throughput screen for transcription activation domains reveals their sequence features and permits prediction by deep learning. Mol Cell. 2020;78:890\u2013902.e6.","journal-title":"Mol Cell"},{"key":"9046_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor-associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18:64.","journal-title":"Mol Cancer"},{"key":"9046_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06207-y","volume":"14","author":"C Wu","year":"2023","unstructured":"Wu C, Zheng C, Chen S, He Z, Hua H, Sun C, et al. FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis. Cell Death Dis. 2023;14:699.","journal-title":"Cell Death Dis"},{"key":"9046_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.biopha.2015.07.010","volume":"74","author":"Y Pei","year":"2015","unstructured":"Pei Y, Wang P, Liu H, He F, Ming L. FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1. Biomed Pharmacother. 2015;74:89\u201394.","journal-title":"Biomed Pharmacother"},{"key":"9046_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10555-025-10240-y","volume":"44","author":"S Koch","year":"2025","unstructured":"Koch S. The transcription factor FOXQ1 in cancer. Cancer Metastasis Rev. 2025;44:22.","journal-title":"Cancer Metastasis Rev"},{"key":"9046_CR19","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3892\/or.2016.5018","volume":"36","author":"X Zhang","year":"2016","unstructured":"Zhang X, Wang L, Wang Y, Shi S, Zhu H, Xiao F, et al. Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A\/MDM2 expression. Oncol Rep. 2016;36:2349\u201356.","journal-title":"Oncol Rep"},{"key":"9046_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.stem.2024.05.008","volume":"31","author":"JS Kirk","year":"2024","unstructured":"Kirk JS, Wang J, Long M, Rosario S, Tracz A, Ji Y, et al. Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells. Cell Stem Cell. 2024;31:1203\u201321.e7.","journal-title":"Cell Stem Cell"},{"key":"9046_CR21","doi-asserted-by":"publisher","first-page":"e1010608","DOI":"10.1371\/journal.pcbi.1010608","volume":"19","author":"Y Gao","year":"2023","unstructured":"Gao Y, Sun F. Batch normalization followed by merging is powerful for phenotype prediction integrating multiple heterogeneous studies. PLoS Comput Biol. 2023;19:e1010608.","journal-title":"PLoS Comput Biol"},{"key":"9046_CR22","doi-asserted-by":"publisher","first-page":"4580.","DOI":"10.3390\/cancers14194580","volume":"14","author":"YS Chang","year":"2022","unstructured":"Chang YS, Chou YP, Chung CC, Lee YT, Yen JC, Jeng LB. Molecular classification of hepatocellular carcinoma using Wnt-hippo signaling pathway-related genes. Cancers. 2022;14:4580.","journal-title":"Cancers"},{"key":"9046_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2021.09.037","volume":"524","author":"FC Cackowski","year":"2022","unstructured":"Cackowski FC, Heath EI. Prostate cancer dormancy and recurrence. Cancer Lett. 2022;524:103\u20138.","journal-title":"Cancer Lett"},{"key":"9046_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu L, Chen W, Qian A, Li YP. Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res. 2024;12:39.","journal-title":"Bone Res"},{"key":"9046_CR25","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.cca.2010.07.006","volume":"411","author":"A Yadav","year":"2010","unstructured":"Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta. 2010;411:1570\u20139.","journal-title":"Clin Chim Acta"},{"key":"9046_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-21-0407","volume":"10","author":"T Miyamoto","year":"2022","unstructured":"Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, et al. B7-H3 suppresses antitumor immunity via the ccl2-ccr2-m2 macrophage axis and contributes to ovarian cancer progression. Cancer Immunol Res. 2022;10:56\u201369.","journal-title":"Cancer Immunol Res"},{"key":"9046_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13115","volume":"54","author":"M Xu","year":"2021","unstructured":"Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Prolif. 2021;54:e13115.","journal-title":"Cell Prolif"},{"key":"9046_CR28","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","volume":"43","author":"MK Georgakis","year":"2022","unstructured":"Georgakis MK, Bernhagen J, Heitman LH, Weber C, Dichgans M. Targeting the CCL2-CCR2 axis for atheroprotection. Eur Heart J. 2022;43:1799\u2013808.","journal-title":"Eur Heart J"},{"key":"9046_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00589-8","volume":"18","author":"Q Hao","year":"2020","unstructured":"Hao Q, Vadgama JV, Wang P. CCL2\/CCR2 signaling in cancer pathogenesis. Cell Commun Signal. 2020;18:82.","journal-title":"Cell Commun Signal"},{"key":"9046_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","volume":"10","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, Seshacharyulu P, Muniyan S, Pothuraju R, Khan P, Vengoji R, et al. GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation. Bone Res. 2022;10:6.","journal-title":"Bone Res"},{"key":"9046_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s11914-019-00545-7","volume":"17","author":"BS Mulholland","year":"2019","unstructured":"Mulholland BS, Forwood MR, Morrison NA. Monocyte chemoattractant protein-1 (MCP-1\/CCL2) drives activation of bone remodelling and skeletal metastasis. Curr Osteoporos Rep. 2019;17:538\u201347.","journal-title":"Curr Osteoporos Rep"},{"key":"9046_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11826-5","volume":"24","author":"J Wang","year":"2024","unstructured":"Wang J, Liu J, Yuan C, Yang B, Pang H, Chen K, et al. Palmitic acid-activated GPRs\/KLF7\/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer. BMC Cancer. 2024;24:75.","journal-title":"BMC Cancer"},{"key":"9046_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.564298","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang H, Zheng J, Bai X, Yue KL, Liang JH, Li DY, et al. Forkhead Box Q1 is critical to angiogenesis and macrophage recruitment of colorectal cancer. Front Oncol. 2020;10:564298.","journal-title":"Front Oncol"},{"key":"9046_CR34","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/hep.26735","volume":"59","author":"L Xia","year":"2014","unstructured":"Xia L, Huang W, Tian D, Zhang L, Qi X, Chen Z, et al. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. Hepatology. 2014;59:958\u201373.","journal-title":"Hepatology"},{"key":"9046_CR35","doi-asserted-by":"publisher","first-page":"21435","DOI":"10.3390\/ijms141121435","volume":"14","author":"HS Wei","year":"2013","unstructured":"Wei HS, Wei HL, Zhao F, Zhong LP, Zhan YT. Glycosyltransferase GLT8D2 positively regulates ApoB100 protein expression in hepatocytes. Int J Mol Sci. 2013;14:21435\u201346.","journal-title":"Int J Mol Sci"},{"key":"9046_CR36","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.21037\/jtd-20-3069","volume":"13","author":"Z Bai","year":"2021","unstructured":"Bai Z, Xu L, Dai Y, Yuan Q, Zhou Z. ECM2 and GLT8D2 in human pulmonary artery hypertension: fruits from weighted gene co-expression network analysis. J Thorac Dis. 2021;13:2242\u201354.","journal-title":"J Thorac Dis"},{"key":"9046_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1082709","volume":"13","author":"D Liu","year":"2022","unstructured":"Liu D, Yin X, Guan X, Li K. Bioinformatic analysis and machine learning to identify the diagnostic biomarkers and immune infiltration in adenomyosis. Front Genet. 2022;13:1082709.","journal-title":"Front Genet"},{"key":"9046_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23649-0","volume":"12","author":"BM Al-Barghouthi","year":"2021","unstructured":"Al-Barghouthi BM, Mesner LD, Calabrese GM, Brooks D, Tommasini SM, Bouxsein ML, et al. Systems genetics in diversity outbred mice inform BMD GWAS and identify determinants of bone strength. Nat Commun. 2021;12:3408.","journal-title":"Nat Commun"},{"key":"9046_CR39","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.21037\/tau-2024-632","volume":"13","author":"W Li","year":"2024","unstructured":"Li W, Zuo K, Zhao Q, Guo C, Liu Z, Liu C, et al. An 11-gene glycosyltransferases-related model for the prognosis of patients with bladder urothelial carcinoma: development and validation based on TCGA and GEO datasets. Transl Androl Urol. 2024;13:2771\u201386.","journal-title":"Transl Androl Urol"},{"key":"9046_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1158863","volume":"13","author":"L Gu","year":"2023","unstructured":"Gu L, Ding D, Wei C, Zhou D. Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics. Front Oncol. 2023;13:1158863.","journal-title":"Front Oncol"},{"key":"9046_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1370367","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Zheng J, Ma Q, Zhang J, Li Y. GLT8D2 is a prognostic biomarker and regulator of immune cell infiltration in gastric cancer. Front Immunol. 2024;15:1370367.","journal-title":"Front Immunol"},{"key":"9046_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01559-y","volume":"16","author":"H Xu","year":"2023","unstructured":"Xu H, Huang K, Lin Y, Gong H, Ma X, Zhang D. Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer. BMC Med Genomics. 2023;16:123.","journal-title":"BMC Med Genomics"},{"key":"9046_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12944-015-0040-3","volume":"14","author":"Y Zhan","year":"2015","unstructured":"Zhan Y, Zhao F, Xie P, Zhong L, Li D, Gai Q, et al. Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liver. Lipids Health Dis. 2015;14:43.","journal-title":"Lipids Health Dis"},{"key":"9046_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00343-w","volume":"10","author":"S Huang","year":"2021","unstructured":"Huang S, Liang S, Chen G, Chen J, You K, Ye H, et al. Overexpression of glycosyltransferase 8 domain-containing 2 confers ovarian cancer to CDDP resistance by activating the FGFR\/PI3K signalling axis. Oncogenesis. 2021;10:55.","journal-title":"Oncogenesis"},{"key":"9046_CR45","first-page":"91","volume":"14","author":"P Ruggiero","year":"2003","unstructured":"Ruggiero P, Flati S, Di Cioccio V, Maurizi G, Macchia G, Facchin A, et al. Glycosylation enhances functional stability of the chemotactic cytokine CCL2. Eur Cytokine Netw. 2003;14:91\u20136.","journal-title":"Eur Cytokine Netw"},{"key":"9046_CR46","doi-asserted-by":"publisher","first-page":"1862.","DOI":"10.3390\/ijms24031862","volume":"24","author":"O Korchynskyi","year":"2023","unstructured":"Korchynskyi O, Yoshida K, Korchynska N, Czarnik-Kwa\u015bniak J, Tak PP, Pruijn GJM. et al. Mammalian glycosylation patterns protect citrullinated chemokine MCP-1\/CCL2 from partial degradation. Int J Mol Sci. 2023;24:1862.","journal-title":"Int J Mol Sci"},{"key":"9046_CR47","doi-asserted-by":"publisher","first-page":"1792.","DOI":"10.3390\/cancers14071792","volume":"14","author":"C Cattrini","year":"2022","unstructured":"Cattrini C, Caffo O, De Giorgi U, Mennitto A, Gennari A, Olmos D. et al. Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC): a critical review. Cancers. 2022;14:1792.","journal-title":"Cancers"},{"key":"9046_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41416-023-02158-5","volume":"128","author":"A Howell","year":"2023","unstructured":"Howell A, Howell SJ. Tamoxifen evolution. Br J Cancer. 2023;128:421\u20135.","journal-title":"Br J Cancer"},{"key":"9046_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06789-1","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Shao K, Yang W, Shen Q, Lu M, Shao Z, et al. Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma. Cell Death Dis. 2024;15:395.","journal-title":"Cell Death Dis"},{"key":"9046_CR50","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1002\/ptr.8184","volume":"38","author":"M Zhou","year":"2024","unstructured":"Zhou M, Niu H, Cui D, Huang G, Li J, Tian H, et al. Resveratrol triggers autophagy-related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1. Phytother Res. 2024;38:3218\u201339.","journal-title":"Phytother Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09046-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09046-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09046-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:49:26Z","timestamp":1789951766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09046-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9046"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09046-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"817"}}